Fewer than 1 in 10 Americans
take in enough choline to meet the adequate intake.
Peer-reviewed analysisAmerican Ginseng Extract is the lead active here, studied most for focus and clear thinking. 12 human studies on American Ginseng Extract back this formula, each one cited. Who it fits: skews toward women, adults.
Verified by IngredientMDThe panel on the left is the one we evaluated, line by line.
All 4 actives checked against the clinical evidence: dose, form, and what the research actually shows.
Doses, ratios, and how the ingredients work together. That assessment is the verdict above: "Stronger in a pair".
The verdict is public and identical whether or not a brand pays. A formula that does not clear the bar gets nothing.
Read by the engine against 2.1 million data points from clinical trials, PubMed and more than a hundred vetted sources. No individual reviewer is named or implied.
Cross-checked against 377 documented interactions for these actives.
Public health figures the engine matched to this formula's ingredients. Reported by their source, cited and dated, never written by the brand.
Fewer than 1 in 10 Americans
take in enough choline to meet the adequate intake.
Peer-reviewed analysis25% of employed US adults
reported difficulty focusing at work in the past month, in the American Psychological Association's 2024 Work in America survey.
American Psychological Association and The Harris Poll, 202412.7% of US adults aged 60 and over
in 21 states reported increased confusion or memory loss in the preceding 12 months, in the 2011 Behavioral Risk Factor Surveillance System.
CDC, MMWR Surveillance Summaries, 201517% of US adults
reported trouble focusing over the past year, in a 2017 Ipsos poll of 1,008 adults.
Ipsos, 201757.6%
During 2017 to 2018, 57.6% of US adults aged 20 and over reported using a dietary supplement in the past 30 days.
CDC National Center for Health Statistics7.4% of US adults
reported serious difficulty concentrating, remembering or making decisions in 2023, up from 5.3% in 2013, and among adults aged 18 to 39 the share nearly doubled, from 5.1% to 9.7%, in the Behavioral Risk Factor Surveillance System.
Neurology, 2025More than 1 in 4 US adults aged 50 to 73
regularly take a supplement for their brain health, rising to 36% of those over 74, and memory is the reason 71% give, in AARP's 2019 survey.
AARP, 201953% of US adults
say they spend too much time on their smartphone, about 7 in 10 of adults under 30, in a Pew Research Center survey of 9,750 adults in 2026.
Pew Research Center, 202659 to 66 days
was the median time it took adults to make a new daily health habit automatic across the studies a 2024 review pooled, with individuals ranging from 4 to 335 days.
Systematic review and meta-analysis, 202461% to 74%
About 61 to 74 percent of adults refilling a long-term medicine on their own stopped within a year, versus 33 to 44 percent on one set pickup day.
Cohort study, 2015USDA advises fortified foods or supplements after 50
In its national intake tables USDA notes that "it is advised that individuals over 50 meet their B12 requirement with fortified foods or supplements".
NHANESRandomised trial, 2010
A single standardised dose improved working memory in healthy young adults, with Corsi block accuracy raised at every dose and testing time across the day.
PsychopharmacologyMeta-analysis, 2022
Across randomised trials in adults with above-normal blood sugar, ginseng lowered fasting glucose modestly compared with control.
NutrientsRandomised trial, 2020
Co-administered with Korean Red ginseng in adults with high blood sugar and elevated blood pressure, it lowered central systolic blood pressure by about 4.7 mmHg over 12 weeks versus control.
Complementary Therapies in MedicineMeta-analysis, 2025
Pooling clinical trials in adults, ginseng supplementation was associated with small improvements in measured markers of blood vessel function.
BMC complementary medicine and therapiesSystematic review, 2023
Across 18 studies, pyridoxine on its own and in combinations improved nausea scores in pregnancy on both the Rhode and PUQE scales, a use with a long clinical track record.
Archives of Gynecology and ObstetricsRandomised trial, 2000
Taken before a glucose load, 3 g reduced the post-meal blood glucose rise by about 19 to 22% in people with high blood sugar and about 18% in those without.
Archives of Internal MedicineRandomised trial, 2019
In adults with high blood sugar, 3 g/day added to usual care lowered HbA1c by about 0.29% and fasting blood glucose by about 0.71 mmol/L over 8 weeks versus placebo.
European Journal of NutritionPopulation figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.
Each line below was derived from this formula's own record at the time of verification. Nothing here was written by the brand, and nothing can be added that the evidence does not carry.
Time-to-effect windows the engine read from the trial record. Each is a window a named study measured, cited and dated, never written by the brand.
An expert consensus on vitamin B6 use, developed by a six-member Delphi panel with a structured evidence-quality assessment, calculated from pharmacokinetic parameters that complete clearance of vitamin B6 from the body takes a washout period of about 20 to 40 days after intake stops.
A randomised, double-blind, parallel-group dose-finding trial in 120 older people with mild vitamin B12 deficiency, defined as serum B12 of 100 to 300 pmol/L with methylmalonic acid at or above 0.26 umol/L, gave daily oral cyanocobalamin at 2.5, 100, 250, 500 or 1000 ug for 16 weeks. Mean plasma methylmalonic acid fell 16%, 16%, 23%, 33% and 33% across those doses. Daily doses of 647 to 1032 ug accounted for 80% to 90% of the estimated maximum reduction. The window was measured on a blood marker of B12 status, not on a symptom.
An open-label randomised single-dose pharmacokinetic study in 20 healthy men aged 20 to 45, conducted and authored by staff of Emisphere Technologies, the developer of the SNAC carrier under test, measured serum vitamin B12 after one 5 mg cyanocobalamin tablet, with six men on the marketed tablet. Time to peak serum B12 was 6.83 hours for the marketed tablet and 0.5 hours for the carrier coformulation. Absolute bioavailability was 2.16% and 5.09% respectively. One trial, six men per arm. Serum concentration was measured, not any symptom.
Windows measured in the cited trials. Context for how the active behaves over time, not a statement about any individual and not a claim about this product.
Four ingredients, from each one's own page.
Nothing quick. Conversion to the active coenzyme happens within hours, but plasma pyridoxal 5-phosphate takes a couple of weeks to settle at a new level.
Markers move first. Methylmalonic acid and homocysteine start shifting within a week or two, while anything you would notice takes several weeks of daily use.
Some people notice steadier attention within two to four hours of a dose. The stress and post-meal glucose work builds over two to four weeks of taking it daily.
Focus effects land within one to two hours of a dose. The power output work measured on that same acute timescale, so this is a same-day ingredient rather than a slow build.
How each ingredient usually behaves over time, from its own page on IngredientMD. General timing for the ingredient, not a measurement of this product.
It is a gummy, which is the format people actually keep taking, and adherence decides whether anything else matters.
Put an earned verification on your own product page.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This record is not medical advice. Always consult your healthcare provider before starting any supplement regimen.